Pesquisa | BVS Integralidade em Saúde

1.

Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer: phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis.

Labidi-Galy, S I; Rodrigues, M; Sandoval, J L; Kurtz, J E; Heitz, F; Mosconi, A M; Romero, I; Denison, U; Nagao, S; Vergote, I; Parma, G; Nøttrup, T J; Rouleau, E; Garnier, G; El-Balat, A; Zamagni, C; Martín-Lorente, C; Pujade-Lauraine, E; Fiévet, A; Ray-Coquard, I L.

Ann Oncol ; 34(2): 152-162, 2023 02.

Artigo em Inglês | MEDLINE | ID: mdl-36564284

2.

Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38): a phase IIIb trial.

Pujade-Lauraine, E; Selle, F; Scambia, G; Asselain, B; Marmé, F; Lindemann, K; Colombo, N; Madry, R; Glasspool, R; Vergote, I; Korach, J; Lheureux, S; Dubot, C; Oaknin, A; Zamagni, C; Heitz, F; Gladieff, L; Rubio-Pérez, M J; Scollo, P; Blakeley, C; Shaw, B; Ray-Coquard, I; Redondo, A.

Ann Oncol ; 34(12): 1152-1164, 2023 12.

Artigo em Inglês | MEDLINE | ID: mdl-37797734

3.

Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial.

Ray-Coquard, I; Leary, A; Pignata, S; Cropet, C; González-Martín, A; Marth, C; Nagao, S; Vergote, I; Colombo, N; Mäenpää, J; Selle, F; Sehouli, J; Lorusso, D; Guerra Alia, E M; Bogner, G; Yoshida, H; Lefeuvre-Plesse, C; Buderath, P; Mosconi, A M; Lortholary, A; Burges, A; Medioni, J; El-Balat, A; Rodrigues, M; Park-Simon, T-W; Dubot, C; Denschlag, D; You, B; Pujade-Lauraine, E; Harter, P.

Ann Oncol ; 34(8): 681-692, 2023 08.

Artigo em Inglês | MEDLINE | ID: mdl-37211045

4.

Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trial.

Frenel, J S; Kim, J W; Aryal, N; Asher, R; Berton, D; Vidal, L; Pautier, P; Ledermann, J A; Penson, R T; Oza, A M; Korach, J; Huzarski, T; Pignata, S; Colombo, N; Park-Simon, T W; Tamura, K; Sonke, G S; Freimund, A E; Lee, C K; Pujade-Lauraine, E.

Ann Oncol ; 33(10): 1021-1028, 2022 10.

Artigo em Inglês | MEDLINE | ID: mdl-35772665

5.

The impact of olaparib dose reduction and treatment interruption on treatment outcome in the SOLO2/ENGOT-ov21 platinum-sensitive recurrent ovarian cancer.

Francis, K E; Kim, S I; Friedlander, M; Gebski, V; Ray-Coquard, I; Clamp, A; Penson, R T; Oza, A; Perri, T; Huzarski, T; Martin-Lorente, C; Cecere, S C; Colombo, N; Ataseven, B; Fujiwara, K; Sonke, G; Vergote, I; Pujade-Lauraine, E; Kim, J-W; Lee, C K.

Ann Oncol ; 33(6): 593-601, 2022 06.

Artigo em Inglês | MEDLINE | ID: mdl-35219776

6.

Should We Abandon Systematic Pelvic and Paraaortic Lymphadenectomy in Low-Grade Serous Ovarian Cancer?

Simon, V; Ngo, C; Pujade-Lauraine, E; Ferron, G; Pomel, C; Leblanc, E; Nadeau, C; Ray-Cocquard, I; Lecuru, F; Bonsang-Kitzis, H.

Ann Surg Oncol ; 27(10): 3882-3890, 2020 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-32246309

7.

New treatments in ovarian cancer.

Pujade-Lauraine, E.

Ann Oncol ; 28(suppl_8): viii57-viii60, 2017 Nov 01.

Artigo em Inglês | MEDLINE | ID: mdl-29232465

8.

Harmonising clinical trials within the Gynecologic Cancer InterGroup: consensus and unmet needs from the Fifth Ovarian Cancer Consensus Conference.

Bookman, M A; Okamoto, A; Stuart, G; Yanaihara, N; Aoki, D; Bacon, M; Fujiwara, K; González-Martín, A; Harter, P; Kim, J W; Ledermann, J; Pujade-Lauraine, E; Quinn, M; Ochiai, K.

Ann Oncol ; 28(suppl_8): viii30-viii35, 2017 Nov 01.

Artigo em Inglês | MEDLINE | ID: mdl-29232472

9.

Quality of life predicts overall survival in women with platinum-resistant ovarian cancer: an AURELIA substudy.

Roncolato, F T; Gibbs, E; Lee, C K; Asher, R; Davies, L C; Gebski, V J; Friedlander, M; Hilpert, F; Wenzel, L; Stockler, M R; King, M; Pujade-Lauraine, E.

Ann Oncol ; 28(8): 1849-1855, 2017 Aug 01.

Artigo em Inglês | MEDLINE | ID: mdl-28595285

10.

Bevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer: exploratory analyses of the AURELIA trial.

Bamias, A; Gibbs, E; Khoon Lee, C; Davies, L; Dimopoulos, M; Zagouri, F; Veillard, A-S; Kosse, J; Santaballa, A; Mirza, M R; Tabaro, G; Vergote, I; Bloemendal, H; Lykka, M; Floquet, A; Gebski, V; Pujade-Lauraine, E.

Ann Oncol ; 28(8): 1842-1848, 2017 Aug 01.

Artigo em Inglês | MEDLINE | ID: mdl-28481967

11.

Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease.

Wilson, M K; Pujade-Lauraine, E; Aoki, D; Mirza, M R; Lorusso, D; Oza, A M; du Bois, A; Vergote, I; Reuss, A; Bacon, M; Friedlander, M; Gallardo-Rincon, D; Joly, F; Chang, S-J; Ferrero, A M; Edmondson, R J; Wimberger, P; Maenpaa, J; Gaffney, D; Zang, R; Okamoto, A; Stuart, G; Ochiai, K.

Ann Oncol ; 28(4): 727-732, 2017 Apr 01.

Artigo em Inglês | MEDLINE | ID: mdl-27993805

12.

Recurrent ovarian cancer.

Pujade-Lauraine, E; Combe, P.

Ann Oncol ; 27 Suppl 1: i63-i65, 2016 04.

Artigo em Inglês | MEDLINE | ID: mdl-27141075

13.

Poor concordance between CA-125 and RECIST at the time of disease progression in patients with platinum-resistant ovarian cancer: analysis of the AURELIA trial.

Lindemann, K; Kristensen, G; Mirza, M R; Davies, L; Hilpert, F; Romero, I; Ayhan, A; Burges, A; Rubio, M J; Raspagliesi, F; Huizing, M; Creemers, G-J; Lykka, M; Lee, C K; Gebski, V; Pujade-Lauraine, E.

Ann Oncol ; 27(8): 1505-10, 2016 08.

Artigo em Inglês | MEDLINE | ID: mdl-27407100

14.

Prognostic and predictive effects of primary versus secondary platinum resistance for bevacizumab treatment for platinum-resistant ovarian cancer in the AURELIA trial.

Trillsch, F; Mahner, S; Hilpert, F; Davies, L; García-Martínez, E; Kristensen, G; Savarese, A; Vuylsteke, P; Los, M; Zagouri, F; Gladieff, L; Sehouli, J; Khoon Lee, C; Gebski, V; Pujade-Lauraine, E.

Ann Oncol ; 27(9): 1733-9, 2016 09.

Artigo em Inglês | MEDLINE | ID: mdl-27287207

15.

A phase III trial of exemestane plus bevacizumab maintenance therapy in patients with metastatic breast cancer after first-line taxane and bevacizumab: a GINECO group study.

Trédan, O; Follana, P; Moullet, I; Cropet, C; Trager-Maury, S; Dauba, J; Lavau-Denes, S; Diéras, V; Béal-Ardisson, D; Gouttebel, M; Orfeuvre, H; Stefani, L; Jouannaud, C; Bürki, F; Petit, T; Guardiola, E; Becuwe, C; Blot, E; Pujade-Lauraine, E; Bachelot, T.

Ann Oncol ; 27(6): 1020-1029, 2016 06.

Artigo em Inglês | MEDLINE | ID: mdl-26916095

16.

Germline BRCA1/2 testing practices in ovarian cancer: Current state and opportunities for new directions.

Lheureux, S; Karakasis, K; Harter, P; Scott, C; Bacon, M; Bryce, J; Le Fur, N; Pujade-Lauraine, E; Oza, A M.

Gynecol Oncol ; 140(1): 90-4, 2016 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-26475959

17.

Translational studies within the TAMRAD randomized GINECO trial: evidence for mTORC1 activation marker as a predictive factor for everolimus efficacy in advanced breast cancer.

Treilleux, I; Arnedos, M; Cropet, C; Wang, Q; Ferrero, J-M; Abadie-Lacourtoisie, S; Levy, C; Legouffe, E; Lortholary, A; Pujade-Lauraine, E; Bourcier, A-V; Eymard, J-C; Spaeth, D; Bachelot, T.

Ann Oncol ; 26(1): 120-125, 2015 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-25361980

18.

Prediction of tumour response induced by chemotherapy using modelling of CA-125 kinetics in recurrent ovarian cancer patients.

Wilbaux, M; Hénin, E; Oza, A; Colomban, O; Pujade-Lauraine, E; Freyer, G; Tod, M; You, B.

Br J Cancer ; 110(6): 1517-24, 2014 Mar 18.

Artigo em Inglês | MEDLINE | ID: mdl-24556626

19.

A phase II study of lenalidomide in platinum-sensitive recurrent ovarian carcinoma.

Selle, F; Sevin, E; Ray-Coquard, I; Mari, V; Berton-Rigaud, D; Favier, L; Fabbro, M; Lesoin, A; Lortholary, A; Pujade-Lauraine, E.

Ann Oncol ; 25(11): 2191-2196, 2014 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-25210017

20.

Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO.

Ray-Coquard, I; Favier, L; Weber, B; Roemer-Becuwe, C; Bougnoux, P; Fabbro, M; Floquet, A; Joly, F; Plantade, A; Paraiso, D; Pujade-Lauraine, E.

Br J Cancer ; 108(9): 1771-7, 2013 May 14.

Artigo em Inglês | MEDLINE | ID: mdl-23612453

BVS Integralidade em Saúde

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar: